Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00597441 · ClinicalTrials.gov registry record · Phase 1
Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation
A Phase 1 study, sponsored by Sumitomo Pharma Switzerland.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00597441: Clinical Trial Phase 1 study, sponsored by Sumitomo Pharma Switzerland.
NCT00597441 is a Phase 1 study that was terminated before completion, run by Sumitomo Pharma Switzerland. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00597441, a Phase 1 study, was terminated before completion, sponsored by Sumitomo Pharma Switzerland.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The objective of this trial is to assess the toxicity of thymus transplantation following unrelated umbilical cord blood transplantation. Emphasis will be placed on adverse events that are not typically associated with umbilical cord blood transplantation. Also, to determine whether engraftment of a third party thymus allograft is feasible in patients who have undergone unrelated umbilical cord blood transplantation.
Interventions
- BIOLOGICAL Thymic Transplantation for Recipients of UCB transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2005-11 |
| Est. Completion | 2010-05 |
| Phase | Phase 1 |
Why NCT00597441 stopped before completion
NCT00597441 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Thymic Transplantation for Recipients of UCB transplant is the first listed.
NCT00597441 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00597441 about?
NCT00597441 is a clinical study titled "Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation". The objective of this trial is to assess the toxicity of thymus transplantation following unrelated umbilical cord blood transplantation. Emphasis will be placed on adverse events that are not typically associated with umbilical cord blood transplantation. Also, to determine whether engraftment of a...
What is the current status of trial NCT00597441?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2005-11. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00597441?
The interventions under investigation include: Thymic Transplantation for Recipients of UCB transplant (BIOLOGICAL).
Who is sponsoring clinical trial NCT00597441?
This trial is sponsored by Sumitomo Pharma Switzerland, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00597441's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia